dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Sissetulev dokumentAvalik

Infokiri

Terviseamet · 10. aprill 2025
Viit
10.1-1/25/51-1
Registreeritud
10. aprill 2025
Dokumendi liik
Sissetulev dokument
Adressaat
MFA
Saabumis/saatmisviis
e-post
Funktsioon
10.1 Kemikaaliohutusega seotud toimingud
Sari
10.1-1 REACH ja CLP kasutajatoe kirjavahetus, info- ja muud dokumendid
Toimik
10.1-1/2025
Vastutaja
Enda Veskimäe (TA, Peadirektori asetäitja (1) vastutusvaldkond, Kemikaaliohutuse osakond)

Failid

  • 📎2025-March-19-SCBP_Summary Report Cover Note.pdf372 KB
  • 📎E-kiri.eml1191 KB
  • 📎SummaryReport_2025-March-19-SCBP_SCBP.pdf493 KB

Sisu (failidest)

Saatja: "Tiiu Noobel" <[email protected]> Saaja: [email protected], "Enda Veskimäe" <[email protected]>, "Maret Voore (SM)" <[email protected]> Teema: FW: Summary report 87th meeting of the Standing Committee on Biocidal Products, 19 March 2025 - Ares(2025)2927827 Kuupäev: 2025-04-10 10:31 Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Edastan. Parimate soovidega Tiiu Noobel Sekretär Eesti Vabariigi alaline esindus EL juures Rue Guimard 11/13, 1040 Brüssel Tel: + 32 2227 4337, [email protected] https://eu.mfa.ee/et/ -----Original Message----- From: Esindus EL juures üldaadress <[email protected]> Sent: Thursday, April 10, 2025 11:46 AM To: Tiiu Noobel <[email protected]> Subject: FW: Summary report 87th meeting of the Standing Committee on Biocidal Products, 19 March 2025 - Ares(2025)2927827 -----Original Message----- From: DOLHA Elena Adriana (SANTE) <[email protected]> Sent: Thursday, April 10, 2025 11:39 AM To: (Mission of Iceland to the EU = Mission de l'Islande auprès de l'UE) <[email protected]>; (Mission of Liechtenstein to the EU = MIssion du Liechtenstein auprès de l'UE) <[email protected]>; (Mission of Switzerland to the EU = Mission de la Suisse auprès de l'UE) <[email protected]>; (Permanent Representation of Austria = Représentation permanente de l'Autriche) <[email protected]>; (Permanent Representation of Belgium = Représentation permanente de la Belgique) <[email protected]>; (Permanent Representation of Bulgaria = Représentation permanente de la Bulgarie) <[email protected]>; (Permanent Representation of Croatia = Représentation permanente de la Croatie) <[email protected]>; (Permanent Representation of Cyprus = Représentation permanente de Chypre) <[email protected]>; (Permanent Representation of Denmark = Représentation permanente du Danemark) <[email protected]>; Esindus EL juures üldaadress <[email protected]>; (Permanent Representation of Finland = Représentation permanente de la Finlande) <[email protected]>; (Permanent Representation of France = Représentation permanente de la France) <[email protected]>; (Permanent Representation of Germany = Représentation permanente de l'Allemagne) <[email protected]>; (Permanent Representation of Greece = Représentation permanente de la Grèce) <[email protected]>; (Permanent Representation of Hungary = Représentation permanente de la Hongrie) <[email protected]>; (Permanent Representation of Ireland = Représentation permanente de l'Irlande) <[email protected]>; (Permanent Representation of Italy = Représentation permanente de l'Italie = Rappresentanza Permanente d’Italia presso l’Uni... <[email protected]>; (Permanent Representation of Latvia = Représentation permanente de la Lettonie) <[email protected]>; (Permanent Representation of Lithuania = Représentation permanente de la Lituanie) <[email protected]>; (Permanent Representation of Luxembourg = Représentation permanente du Luxembourg) <[email protected]>; (Permanent Representation of Malta = Représentation permanente de Malte) <[email protected]>; (Permanent Representation of Netherlands = Représentation permanente des Pays-Bas) <[email protected]>; (Permanent Representation of Poland = Représentation permanente de la Pologne) <[email protected]>; (Permanent Representation of Portugal = Représentation permanente du Portugal) <[email protected]>; (Permanent Representation of Romania = Représentation permanente de la Roumanie) <[email protected]>; (Permanent Representation of Slovakia = Représentation permanente de la Slovaquie) <[email protected]>; (Permanent Representation of Slovenia = Représentation permanente de la Slovénie) <[email protected]>; (Permanent Representation of Spain = Représentation permanente d'Espagne) <[email protected]>; (Permanent Representation of Sweden = Représentation permanente de Suède) <[email protected]>; (Permanent Representation of the Czech Republic = Représentation permanente de la République tchèque) <[email protected]> Subject: Summary report 87th meeting of the Standing Committee on Biocidal Products, 19 March 2025 - Ares(2025)2927827 Dear all, Please find attached the summary report of the Standing Committee on Biocidal Products 19 march 2025. Kind regards, Elena Dolha Ref. Ares(2025)2927827 - 10/04/2025 EUROPEAN COMMISSION Health and Food Safety Directorate General sante.g.3(2025)4319821 87th Standing Committee on Biocidal Products 19 March 2025 CIRCABC Link: https://circabc.europa.eu/ui/group/8b6b0199-c74b-43bd-a9dd- 79bdcae3b825/library/9e8ba86c-5490-4874-86b4-8d46f1414a09?p=1&n=10&sort=modified_DESC SUMMARY REPORT A.01 Adoption of the Agenda The agenda was adopted. A.02 Adoption of the minutes of the 86th SCBP meeting The minutes of the 86th SCBP meeting were adopted. A.03 Discussion on the application of approval of formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1), as an existing active substance for use in biocidal products of product-types 2, 6, 11 and 13 , and of reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) as an existing active substance for use in biocidal products of product-types 2, 6, 11, 12 and 13 A discussion took place on the application of approval of formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1), as an existing active substance for use in biocidal products of product-types 2, 6, 11 and 13, and of reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2) as an existing active substance for use in biocidal products of product-types 2, 6, 11, 12 and 13. A.04 Discussion on the application of approval of DBNPA as an existing active substance for use in biocidal products of product-type 11 A discussion took place on the application of approval of DBNPA as an existing active substance for use in biocidal products of product-type 11. A.05 Discussion on the application of renewal of approval of medetomidine as an existing active substance for use in biocidal products of product-type 21 A discussion took place on the application of renewal of approval of medetomidine as an existing active substance for use in biocidal products of product-type 21. A.06 Information on a draft Commission Implementing Regulation specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (repealing Commission Implementing Regulation (EU) No 414/201) The Commission provided information on a draft Implementing Regulation specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (repealing Commission Implementing Regulation (EU) No 414/2013). A.07 Information on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product families Cypermethrin liquids and Cypermethrin solids, and on the biocidal product Icon 10 CS, in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission informed that internal discussions are still on-going within the Commission. A.08 Information on decisions on amendments to Union authorisations under preparation or published The Commission informed on amendments to Union authorisations under preparation or published. The Commission recalled the importance of the quality check of the translations of the Summary of Products Characteristics annexed to the authorisation. B.01 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Decision on the non-approval of ethylene oxide for use in biocidal products of product type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.02 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.03 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation approving formic acid as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.04 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation approving 1,2-Benzisothiazol-3(2H)-one (BIT) as an existing active substance for use in biocidal products of product-types 6 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.05 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the biocidal product family ‘B.Braun Medical Propanol Family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.06 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the biocidal product family ‘BPF Propan-2-ol Dr Deppe’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.07 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the single biocidal product ‘Fernox Biocide AF10’, in accordance with Regulation (EU) No 582/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.08 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the single biocidal product ‘Hydrocid 306’, in accordance with Regulation (EU) No 582/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.09 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the biocidal product family ‘PAA family UCO Group’, in accordance with Regulation (EU) No 582/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place, and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed B.10 Exchange of views and possible opinion of the Committee on a draft Commission Implementing Decision concerning the extension of the action taken by the Environment Agency of Luxembourg permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Commission informed that the draft will be included in the next written consultation of the Standing Committee. Vote Postponed C.01 Exchange of views of the Committee on a draft Commission Implementing Regulation amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.02 Exchange of views of the Committee on a draft Commission Implementing Regulation approving 2-methyl-2H-isothiazol-3-one (MIT) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.03 Exchange of views of the Committee on a draft Commission Implementing Regulation approving 2-methyl-2,3-dihydro-1,2-thiazol-3-one hydrochloride for use in biocidal products of product type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.04 Exchange of views of the Committee on a draft Commission Implementing Regulation approving peracetic acid generated from 1,3-diacetyloxypropan-2-yl acetate and hydrogen peroxide as an existing active substance for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.05 Exchange of views of the Committee on a draft Commission Implementing Regulation renewing the approval of epsilon-metofluthrin as an active substance for use in biocidal products of product type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.06 Exchange of views of the Committee on a draft Commission Implementing Decision repealing Implementing Decision (EU) 2024/2460 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.07 Exchange of views of the Committee on a draft Commission Implementing Decision on the non-approval of epsilon-metofluthrin for use in biocidal products of product type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council As the draft Decision was not yet available, no discussion took place on this agenda item. C.08 Exchange of views of the Committee on a draft Commission Implementing Decision not approving certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.09 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval of nonanoic acid for use in biocidal products of product-type 2 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.10 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval of bis(N-cyclohexyl- diazenium-dioxy)-copper (Cu-HDO) for use in biocidal products of product-type 8 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.11 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval decanoic acid for use in biocidal products of product-type 4 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.12 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval octanoic acid for use in biocidal products of product-type 8 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.13 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval iodine for use in biocidal products of product-type 3 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.14 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval polyvinylpyrrolidone iodine for use in biocidal products of product-types 1 and 3 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.15 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval 1R-trans phenothrin for use in biocidal products of product-type 18 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.16 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval S-methoprene for use in biocidal products of product-type 18 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.17 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval medetomidine for use in biocidal products of product-type 21 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.18 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval IPBC for use in biocidal products of product-type 8 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.19 Exchange of views of the Committee on a draft Commission Implementing Decision (EU) postponing the expiry date of the approval DDACarbonate for use in biocidal products of product-type 8 The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.20 Exchange of views of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the biocidal product family ‘desmanol pure’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.21 Exchange of views of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the single biocidal product ‘exeol air cid 01’, in accordance with Regulation (EU) No 582/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.22 Exchange of views of the Committee on a draft Commission Implementing Regulation (EU) granting a Union authorisation for the biocidal product family ‘PRODHYNET's Lactic acid based products’, in accordance with Regulation (EU) No 582/2012 of the European Parliament and of the Council The Commission introduced the draft Regulation. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.23 Exchange of views of the Committee on a draft Commission Implementing Regulation granting a Union authorisation for the biocidal product family ‘CHLOROCRESOL BASED PRODUCTS-CID Lines NV’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission explained that no documents were provided but that following the receipt of the Agency’s opinion on an Article 75(1)(g) request a revised version will be prepared for the next meeting. C.24 Exchange of views of the Committee on a draft Commission Implementing Decision concerning the extension of the action taken by the Ministry of Health of the Czech Republic permitting the making available on the market and use of the biocidal product Tandem in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. C.25 Exchange of views of the Committee on a draft Commission Implementing Decision concerning the extension of the action taken by the Dutch Ministry of Infrastructure and Water Management permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council The Commission introduced the draft Decision. A discussion took place and the Committee agreed that the draft will be included in a written consultation of the Standing Committee as soon as possible. Electronically signed on 09/04/2025 12:23 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121 Ref. Ares(2025)2927827 - 10/04/2025 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.g.3(2025)4319821 To: Permanent Representations of all 27 Member States Missions of Iceland, Norway and Switzerland Copy to: Contacts Standing Committee on Biocidal Products of all 27 Member States - preset Contacts DG Health and Food Safety and other - preset Summary Report Health and Food Safety Directorate General / Unit E4 Meeting: Standing Committee on Biocidal Products Date: 19 March 2025 Summary Report: Attached in Annex 1 Please find attached the Summary Report of the Standing Committee Meeting on Biocidal Products, held on 19 March 2025. N.B. The drafts on which the Committee expressed an opinion are subject to a defined procedure in relation to the formal adoption by the Commission. BITTERHOF Almut Acting Head of Unit Annex 1 – Summary Report HANS INGELS(GROW.F.2) DE AVILA Cristina(ENV.B.2) Electronically signed on 09/04/2025 12:23 (UTC+02) European in accordance Commission, – Belgium B-1049 Brusselswith Article 11 of Commission Decision (EU) 2021/2121 Telephone (+32-2) 299.11.11 Office B-B232 03/071 Telephone direct line (+32-2) 296.33.56 E-Mail-Address: [email protected]
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel